Reported May 7, 2014 · Terminated
Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber…
AbbVie Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AbbVie Inc · 1 N Waukegan Rd · North Chicago, IL · 60064
Is this the product you have?
- Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only
- Manufactured forAbbVie Inc., North Chicago, IL 60064
- by
Takeda Pharmaceutical Company LimitedOsakaJapan 540-8645NDC 0074-3346-03UPC 3 00743 34603 9
- Lot codes and dates
Lot #: 1014204Exp 10/11/151014485Exp 12/11/16and 1015007Exp 12/06/16
- Amount recalled
- 7362 kits
This recall covers 5 products
The agency filed one notice per product. You are reading one of them; the other 4 are below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AbbVie Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.